back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-01-14 12:42 Tx date 2020-01-10 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,390,000 | |
| Filed 2018-05-23 Tx date 2018-05-23 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,750
+250,000 vol $0.035 each |
4,573,010 | |
| Filed 2018-05-23 Tx date 2018-05-18 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,500
+500,000 vol $0.035 each |
3,873,010 | |
| Filed 2018-05-23 Tx date 2018-05-22 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,750
+450,000 vol $0.035 each |
4,323,010 | |
| Filed 2016-07-08 Tx date 2016-07-06 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,000
+400,000 vol $0.035 each |
3,373,010 | |
| Filed 2016-02-10 Tx date 2016-02-10 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,920
+148,000 vol $0.04 each |
2,973,010 | |
| Filed 2016-02-09 Tx date 2016-02-08 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,995
+57,000 vol $0.035 each |
2,780,010 | |
| Filed 2016-02-09 Tx date 2016-02-09 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,575
+45,000 vol $0.035 each |
2,825,010 | |
| Filed 2016-01-25 Tx date 2016-01-22 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,410
+47,000 vol $0.03 each |
2,520,010 | |
| Filed 2016-01-25 Tx date 2016-01-25 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,090
+203,000 vol $0.03 each |
2,723,010 | |
| Filed 2016-01-21 Tx date 2016-01-21 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,730
+491,000 vol $0.03 each |
2,473,010 | |
| Filed 2016-01-21 Tx date 2016-01-20 |
$ICO
iCo Therapeutics Inc. |
Rae, Andrew Rae
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$225.00
+9,000 vol $0.025 each |
1,982,010 |